ABI
BAX icon

Adamant Biomedical Investments’s Baxter International BAX Stock Holding History

Adamant Biomedical Investments’s Portfolio BAX Stock Details BAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		$4.76M Hold
119,665
– – 1.14% 32
2014
Q3 		$4.67M Buy
+119,665
New +$4.86M 1.16% 31

Other funds holding BAX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
AAM
Aberdeen Asset Management Aberdeen, United Kingdom $30B AUM 22.69% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
BBHC
Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Adamant Biomedical Investments's BAX Position: Q4 2014 in Review

Adamant Biomedical Investments held its Baxter International (BAX) position steady in Q4 2014 at 119,665 shares worth $4.76M. The position accounts for 1.14% of the portfolio, ranked #32.

Adamant Biomedical Investments first reported a position in BAX in Q3 2014 and has held it in 2 quarters since. 1,060 funds tracked by Wall St. Rank hold BAX as of Q4 2014.

  • Adamant Biomedical Investments held 119,665 shares of Baxter International worth $4.76M as of Q4 2014.
  • Adamant Biomedical Investments left its Baxter International share count unchanged in Q4 2014.
  • Baxter International made up 1.14% of Adamant Biomedical Investments's portfolio in Q4 2014, its #32 holding.
  • Adamant Biomedical Investments first reported a position in Baxter International in Q3 2014 and has held it in 2 quarters since.
  • 1,060 funds tracked by Wall St. Rank held Baxter International as of Q4 2014.

Based on Adamant Biomedical Investments's 13F filing for Q4 2014, filed 13 Feb 2015.